The Do's and Don'ts of a Medicaid Spend-Down
6 Unusual Ways to Make Money From Home
Restaurant Reservations Are Broken. Here's a Simple Fix
How to Invest in Bonds When Interest Rates Rise
Biotech M&A Outlook Boosted By AbbVie Deal, Says This RBC Analyst
Trade-Ideas: Medivation (MDVN) Is Today's New Lifetime High Stock
Tuesday 3/3 Insider Buying Report: MDVN, QSR
Will Medivation Kick J&J To The Curb For This $9 Billion Market?
Pharmacyclics: Is A $19 Billion Valuation Reasonable?
Medivation (MDVN) Shares March Higher, Can It Continue? - Tale of the Tape
Amgen Reports Encouraging Late-Stage Data on AMG 416 - Analyst Blog
Medivation Beats on Q4 Earnings & Revenues; Xtandi Soars - Analyst Blog
Medivation's (MDVN) CEO David Hung on Q4 2014 Results - Earnings Call Transcript
Medivation (MDVN) Q4 2014 Results - Earnings Call Webcast